Correlation of Insulin Resistance Indexes with Blood levels of Zonulin, clusterin in patients with Nonalcoholic Fatty Liver Disease
Keywords:
Zonulin, hepatic steatosis, HOMA-IR, TyG IndexAbstract
Background: Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder affecting approximately 25% of the global population. It is closely linked to insulin resistance (IR), obesity, type 2 diabetes, and metabolic syndrome.
Objectives: The of this study to analyze the correlation between insulin resistance indexes (HOMA-IR, TyG Index) and serum levels of zonulin and clusterin in patients with NAFLD.
Method and materials: A case-control study was conducted at Kirkuk Teaching Hospital in Iraq. The study took place from September 15, 2024, to January 18, 2025, and included 90 participants between 30 and 60 years of age─60 patients diagnosed with NAFLD (30 males and 30 females) and 30 healthy controls (15 males and 15 females). Serum measurements of fasting blood glucose (FBS) and triglycerides (TG) were performed using automated biochemical analyzers. Fasting insulin, zonulin, and clusterin were estimated by enzyme-linked immunosorbent assay (ELISA).
Results: NAFLD patients exhibited significantly higher fasting blood sugar (132.94 ± 21.34 mg/dL vs. 100.19 ± 10.61 mg/dL, p<0.01), triglycerides (191.19 ± 19.04 mg/dL vs. 144.53 ± 16.48 mg/dL, p<0.01), insulin (19.98 ± 4.54 mIU/mL vs. 8.97 ± 3.47 mIU/mL, p<0.01), HOMA-IR (6.73 ± 2.44 vs. 2.27 ± 1.03, p<0.01), and TyG Index (9.43 ± 0.23 vs. 8.88 ± 0.20, p<0.01) than controls. Zonulin (72.50 ± 8.24 ng/mL vs. 57.17 ± 8.26 ng/mL, p<0.01) and clusterin (186.82 ± 25.29 ng/mL vs. 132.79 ± 21.76 ng/mL, p<0.01) were also significantly elevated. Correlation analysis showed zonulin and clusterin were positively associated with insulin resistance markers (HOMA-IR, fasting insulin and TyG Index; p<0.01). ROC curve analysis revealed HOMA-IR (AUC = 0.975) as the most powerful diagnostic marker, followed by TyG Index (AUC = 0.966), clusterin (AUC = 0.945), and zonulin (AUC = 0.903).
Conclusions: Zonulin, and clusterin levels were significantly higher in patients with NAFLD, HOMA-IR remains the best predictor of NAFLD, while TyG Index, clusterin, and zonulin may serve as additional biomarkers.
Downloads
Metrics
References
Jin Y, Heo KS. Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development. The Korean Journal of Physiology & Pharmacology. 2023 Jul 1;27(4):299–310.
Dhurgham A. Mahmood Yaser A.M Sulaiman, Kasim Sakran Abass. Evalution of liver function tests in patients with psoriasis. Evalution of liver function tests in patients with psoriasis. Revista Latinoamericana de Hipertensión. 2022;17( Nº 6): 396-403
Mahmood Dh. A.,Relationship between Paraoxonase and Malondialdehyde as a marker of oxidative stress in patients with psoriasis. Revista Latinoamericana de Hipertensión. 2022;17( Nº 6): 404-409.
Chen H. Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease. Liver Res. 2020 Mar;4(1):15–22.
Sarhat, E.R., Abbas, M.Q., Ali, N.H., Wadi, S.A., Sarhat, T.R. Evalution of Ceruloplasmin, Sialic Acid and Liver Function for Women with Breast Cancer. AIP.2022; 2394( 1):6.
Fatma S. Abd-Alqader. EVALUATION OF THE ROLE OF COENZYME Q 10 IN THE BLOOD OF BREAST CANCER WOMEN,2023; 5 (338):91-95.
Yahoo N, Dudek M, Knolle P, Heikenwälder M. Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation. J Hepatol. 2023 Aug;79(2):538–51.
Saleh, N.I.S.; Wadee, S.A.; Sarhat, E.R. Minimizing the side effects of Doxorubicin Induced Hepatotoxicity by using alcoholic extract of Date Palm in adult rats .Revista Bionatura 2023;8 (2) 63. http://dx.doi.org/10.21931/RB/CSS/2023.08.04.03.
Hussain I. Hussain, Elham M. Mahmood, Saif Kamil, Huda A. Hameed, Samira AH. Abdulla, Entedhar R. Sarhat. Chloroquine Induced Lesions in the Visceral Tissues of Albino Mice.Bahrain Medical Bulletin,2024; 46(3): 2313─ 2317
Sarhat RS, Siham A.W, Ayhan R. M. Effect of Ethanolic Extraction of Moringa oleifera on Paraoxonase and Arylesterase enzyme activity in High Fat Diet-induced Obesity in Rats. Research J. Pharm. and Tech.2018; 11(10): 4601-4. 8.
Mahmmod M, Sarhat E. HEPCIDIN AND FERRITIN MODULATED IN OBESE MALE. Georgian Med News. 2023 Nov;(344):114-118. PMID: 38236110.
Salim J. Khalaf, Moayad M. Al Anzy, Entedhar R. Sarhat. Impact of Metformin On Osteoprotegerin levels In Polycystic Ovarian Women. GMN;.2024; 1 (346) 2024:144-146
Jihad AT Levels of AMH and Hepcidin as Potential Biomarkers for Polycystic Ovary Syndrome. Georgian medical news.2023; 6 (339):47-51.
Tawfeq MT. Metformin effects on neuregulin-1 in polycystic ovarian women. Georgian medical news. 2023;4:56- 62.
Allow SM. Metformin effects on blood levels of gremlin-1 in polycystic ovarian women. Georgian medical news. 2023;337:51-55.
Seethaler B, Basrai M, Neyrinck AM, Nazare JA, Walter J, Delzenne NM, et al. Biomarkers for assessment of intestinal permeability in clinical practice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2021 Jul 1;321(1):G11–7.
Sultana P, Novotny J. Clusterin: a double-edged sword in cancer and neurological disorders. EXCLI J. 2024;23:912.
Biernacka-Bartnik A, Kocełak P, Owczarek AJ, Choręza PS, Markuszewski L, Madej P, et al. The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome. Front Med (Lausanne). 2023 Mar 10;10.
Song S, Son DH, Baik SJ, Cho WJ, Lee YJ. Triglyceride Glucose-Waist Circumference (TyG-WC) is a Reliable Marker to Predict Non-Alcoholic Fatty Liver Disease. 2022.
Mashahit M, Hamad A, Zaki O. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes? Fayoum University Medical Journal. 2019;4(1):21–9.
Hong S hyeon, Lee JS, Kim JA, Lee YB, Roh E, Hee Yu J, et al. Glycemic variability and the risk of nonalcoholic fatty liver disease : A nationwide population-based cohort study. Diabetes Res Clin Pract. 2021 Jul;177:108922.
Motamed B, Vajargah MK, Kalantari S, Shafaghi A. HOMA-IR index in non-diabetic patient, a reliable method for early diagnosis of liver steatosis. Caspian J Intern Med. 2022;13(3):519.
Reda Albadawy AMEB. Diagnostic Accuracy of HOMA-IR in Detecting and Grading Nonalcoholic Fatty Liver Disease. Egypt J Hosp Med. 2023 Oct 1;93(1):7018–7005.
Zeng P, Cai X, Yu X, Gong L. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population. Sci Rep. 2023 Nov 22;13(1):20470.
Simental-Mendía LE, Simental-Mendía E, Rodríguez-Hernández H, Rodríguez-Morán M, Guerrero-Romero F. The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women. Ann Hepatol. 2017;15(5):715–20.
Peng H, Pan L, Ran S, Wang M, Huang S, Zhao M, et al. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults. Front Endocrinol (Lausanne). 2023 Jan 19;14.
Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017 Dec 19;16(1):15.
Wang Y, Shen Y, Hu T, Wang Y, Ma X, Yu H, et al. Associations between serum clusterin levels and non-alcoholic fatty liver disease. Endocr Connect. 2023 Apr 12;12(7).
Park JS, Lee WK, Kim HS, Seo JA, Kim DH, Han HC, et al. Clusterin overexpression protects against western diet-induced obesity and NAFLD. Sci Rep. 2020 Oct 15;10(1):17484.
Wittwer J, Bradley D. Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome. Front Immunol. 2021 Feb 25;12.
Jeon YK, Kim SS, Kim JH, Kim HJ, Kim HJ, Park JJ, et al. Combined Aerobic and Resistance Exercise Training Reduces Circulating Apolipoprotein J Levels and Improves Insulin Resistance in Postmenopausal Diabetic Women. Diabetes Metab J. 2020;44(1):103.
Rull A, Martínez-Bujidos M, Pérez-Cuellar M, Pérez A, Ordóñez-Llanos J, Sánchez-Quesada JL. Increased concentration of clusterin/apolipoprotein J (apoJ) in hyperlipemic serum is paradoxically associated with decreased apoJ content in lipoproteins. Atherosclerosis. 2015 Aug;241(2):463–70.
Pacifico L. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(45):17107.
Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, et al. Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives. Diabetes. 2006 May 1;55(5):1443–9.
Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proceedings of the National Academy of Sciences. 2009 Sep 29;106(39):16799–804.
Machado M, Cortez-Pinto H. Non-alcoholic fatty liver disease and insulin resistance. Eur J Gastroenterol Hepatol. 2005;17(8).
Hendy OM, Elsabaawy MM, Aref MM, Khalaf FM, Oda AMA, El Shazly HM. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease. APMIS. 2017 Jul 21;125(7):607–13.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
